About Beecher Lewis
Form D filings for Nexsis Biosciences in 2024 list Beecher Lewis as executive officer and director.
Beecher Lewis first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Beecher Lewis in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Beecher Lewis works with at each company, as listed on that company's latest Form D.
Nexsis Biosciences LLC · Form D, Jun 24, 2024
SC
Scott Cart
Executive officer and director
JP
John Pirris
Director
JJ
John Thomas, Jr.
Chief Financial Officer